Safety Hypodermic Needle Prevents Needlestick Injury
By HospiMedica International staff writers Posted on 18 Jan 2016 |
A new range of intuitive hypodermic needles provide an integrated safety solution to help eliminate needlestick injuries.
The VACUETTE CLIX Safety Hypodermic Needle is a versatile product that comes with a wide range of needle thicknesses and lengths, all easily distinguishable from each other thanks to their color-coded shields. Safety features include a double lock mechanism to fix the needle, and an integrated safety shield which can be activated using a solid surface or the user's thumb. When an audible click is heard, it indicates that the safety shield is positioned securely around the needle, and that the needle can be triaged without risk of injury.
The Latex-free, non-pyrogenic, non-toxic, VACUETTE CLIX Safety Hypodermic is a product of Greiner Bio-One (GBO; Kremsmünster, Austria), and is intended both for taking venous blood samples and for giving injections. It is designed to be used with a range of standard Luer syringes, as well as with the proprietary GBO HOLDEX tube holder, which has an eccentric Luer fitting that provides for a flatter puncture angle, thus increasing comfort for both patient and user.
“For many healthcare workers, needlestick injuries carry a high risk of infection with blood-borne pathogens such as hepatitis C and HIV, with recent studies revealing significantly higher levels of affliction amongst people in hospitals than in the wider population,” stated GBO in a press release. “Given the trauma experienced by those affected as well as the substantial consequential costs, Greiner Bio-One has added another new product to its range of safety solutions in an attempt to eliminate this risk as far as possible.”
While most needlestick injuries carry no adverse health consequences, a possibility of infection from more than 20 different infectious agents is present, including human immunodeficiency virus (HIV), Hepatitis B virus (HBV), and Hepatitis C virus (HCV). The rate of infection after needlestick exposure has been calculated for HIV as 0.3%; figures for HCV and HBV have been reported as 1.7% and as high as 30%, respectively. Exposure to significant quantities of blood or deep needle punctures increases the likelihood of infection.
Related Links:
Greiner Bio-One
The VACUETTE CLIX Safety Hypodermic Needle is a versatile product that comes with a wide range of needle thicknesses and lengths, all easily distinguishable from each other thanks to their color-coded shields. Safety features include a double lock mechanism to fix the needle, and an integrated safety shield which can be activated using a solid surface or the user's thumb. When an audible click is heard, it indicates that the safety shield is positioned securely around the needle, and that the needle can be triaged without risk of injury.
The Latex-free, non-pyrogenic, non-toxic, VACUETTE CLIX Safety Hypodermic is a product of Greiner Bio-One (GBO; Kremsmünster, Austria), and is intended both for taking venous blood samples and for giving injections. It is designed to be used with a range of standard Luer syringes, as well as with the proprietary GBO HOLDEX tube holder, which has an eccentric Luer fitting that provides for a flatter puncture angle, thus increasing comfort for both patient and user.
“For many healthcare workers, needlestick injuries carry a high risk of infection with blood-borne pathogens such as hepatitis C and HIV, with recent studies revealing significantly higher levels of affliction amongst people in hospitals than in the wider population,” stated GBO in a press release. “Given the trauma experienced by those affected as well as the substantial consequential costs, Greiner Bio-One has added another new product to its range of safety solutions in an attempt to eliminate this risk as far as possible.”
While most needlestick injuries carry no adverse health consequences, a possibility of infection from more than 20 different infectious agents is present, including human immunodeficiency virus (HIV), Hepatitis B virus (HBV), and Hepatitis C virus (HCV). The rate of infection after needlestick exposure has been calculated for HIV as 0.3%; figures for HCV and HBV have been reported as 1.7% and as high as 30%, respectively. Exposure to significant quantities of blood or deep needle punctures increases the likelihood of infection.
Related Links:
Greiner Bio-One
Read the full article by registering today, it's FREE!
Register now for FREE to HospiMedica.com and get complete access to news and events that shape the world of Hospital Medicine.
- Free digital version edition of HospiMedica International sent by email on regular basis
- Free print version of HospiMedica International magazine (available only outside USA and Canada).
- Free and unlimited access to back issues of HospiMedica International in digital format
- Free HospiMedica International Newsletter sent every week containing the latest news
- Free breaking news sent via email
- Free access to Events Calendar
- Free access to LinkXpress new product services
- REGISTRATION IS FREE AND EASY!
Sign in: Registered website members
Sign in: Registered magazine subscribers
Latest Critical Care News
- Powerful AI Risk Assessment Tool Predicts Outcomes in Heart Failure Patients
- Peptide-Based Hydrogels Repair Damaged Organs and Tissues On-The-Spot
- One-Hour Endoscopic Procedure Could Eliminate Need for Insulin for Type 2 Diabetes
- AI Can Prioritize Emergency Department Patients Requiring Urgent Treatment
- AI to Improve Diagnosis of Atrial Fibrillation
- Stretchable Microneedles to Help In Accurate Tracking of Abnormalities and Identifying Rapid Treatment
- Machine Learning Tool Identifies Rare, Undiagnosed Immune Disorders from Patient EHRs
- On-Skin Wearable Bioelectronic Device Paves Way for Intelligent Implants
- First-Of-Its-Kind Dissolvable Stent to Improve Outcomes for Patients with Severe PAD
- AI Brain-Age Estimation Technology Uses EEG Scans to Screen for Degenerative Diseases
- Wheeze-Counting Wearable Device Monitors Patient's Breathing In Real Time
- Wearable Multiplex Biosensors Could Revolutionize COPD Management
- New Low-Energy Defibrillation Method Controls Cardiac Arrhythmias
- New Machine Learning Models Help Predict Heart Disease Risk in Women
- Deep-Learning Model Predicts Arrhythmia 30 Minutes before Onset
- Breakthrough Technology Combines Detection and Treatment of Nerve-Related Disorders in Single Procedure